Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin.
Department of Health Informatics and Administration, University of Wisconsin-Milwaukee.
Otol Neurotol. 2022 Oct 1;43(9):1078-1084. doi: 10.1097/MAO.0000000000003652. Epub 2022 Aug 4.
To identify demographic and clinical features impacting initial treatment pathway for vestibular schwannoma.
Retrospective chart review.
Tertiary care academic medical center.
Patients diagnosed with vestibular schwannoma between 2009 and 2019.
Observation, stereotactic radiosurgery, or microsurgical resection.
χ 2 Test, one-way analysis of variance, and multivariate logistic regression were used to correlate demographic and clinical factors with initial treatment pathway for 197 newly diagnosed vestibular schwannoma patients.
Among 197 patients, 93 (47%) were initially treated with observation, 60 (30%) with stereotactic radiation (Gamma Knife) and 44 (22%) with surgical resection. Age univariately had no statistically significant impact on initial pathway, but those undergoing surgery trended toward a younger demographic (49.1 yr [surgery] versus 57.2 yr [observation] versus 59.0 yr [Gamma Knife]). Men were more likely to be initially observed than women ( p = 0.04). Patients initially observed were more likely to have a lower Koos classification ( p < 0.001) and have better tumor-ear hearing ( p = 0.03). Only 34.4% of patients living outside the local geographic region were initially observed compared with 53.0% living locally ( p = 0.055). Surgeon correlated with initial treatment ( p = 0.04) but did not maintain significance when adjusting for hearing level or tumor size. A multiple linear regression model found age, maximum tumor diameter, and Koos class to correlate with initial treatment pathway ( p < 0.0001, r2 = 0.42).
Initial treatment pathway for newly diagnosed vestibular schwannoma is impacted by demographic factors such as age, sex, and geographic proximity to the medical center. Clinical features including hearing level and tumor size also correlated with initial treatment modality.
确定影响前庭神经鞘瘤初始治疗途径的人口统计学和临床特征。
回顾性图表审查。
三级保健学术医疗中心。
2009 年至 2019 年间被诊断为前庭神经鞘瘤的患者。
观察、立体定向放射外科手术或显微切除术。
χ2 检验、单因素方差分析和多变量逻辑回归用于分析 197 例新诊断前庭神经鞘瘤患者的人口统计学和临床因素与初始治疗途径的相关性。
在 197 例患者中,93 例(47%)最初接受观察治疗,60 例(30%)接受立体定向放射治疗(伽玛刀),44 例(22%)接受手术切除。年龄单因素分析对初始途径没有统计学意义,但接受手术的患者年龄偏轻(49.1 岁[手术]与 57.2 岁[观察]与 59.0 岁[伽玛刀])。男性比女性更有可能最初接受观察治疗(p=0.04)。最初接受观察治疗的患者更有可能具有较低的 Koos 分级(p<0.001)和更好的肿瘤-耳听力(p=0.03)。与居住在当地的患者(53.0%)相比,居住在外地的患者(34.4%)更不可能最初接受观察治疗(p=0.055)。外科医生与初始治疗相关(p=0.04),但在调整听力水平或肿瘤大小后,这种相关性不再具有统计学意义。多元线性回归模型发现年龄、最大肿瘤直径和 Koos 分级与初始治疗途径相关(p<0.0001,r2=0.42)。
新诊断的前庭神经鞘瘤的初始治疗途径受到年龄、性别和与医疗中心的地理距离等人口统计学因素的影响。临床特征包括听力水平和肿瘤大小也与初始治疗方式相关。